 | • レポートコード：MRC2-11QY11873 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はエピゲノムのグローバル市場について調査・分析したレポートです。種類別（試薬、キット、器具、酵素、サービス）市場規模、用途別（腫瘍、非腫瘍）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別エピゲノムの競争状況、市場シェア ・世界のエピゲノム市場：種類別市場規模 2015年-2020年（試薬、キット、器具、酵素、サービス） ・世界のエピゲノム市場：種類別市場規模予測 2021年-2026年（試薬、キット、器具、酵素、サービス） ・世界のエピゲノム市場：用途別市場規模 2015年-2020年（腫瘍、非腫瘍） ・世界のエピゲノム市場：用途別市場規模予測 2021年-2026年（腫瘍、非腫瘍） ・北米のエピゲノム市場分析：米国、カナダ ・ヨーロッパのエピゲノム市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのエピゲノム市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のエピゲノム市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのエピゲノム市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Roche Diagnostics、Thermo Fisher Scientific、Eisai、Novartis ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Epigenomics is the study of the complete set of epigenetic modifications on the genetic material of a cell, known as the epigenome. The field is analogous to genomics and proteomics, which are the study of the genome and proteome of a cell.
Market Analysis and Insights: Global Epigenomic Market
The global Epigenomic market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Epigenomic Scope and Market Size
Epigenomic market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Epigenomic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Roche Diagnostics
Thermo Fisher Scientific
Eisai
Novartis
…
Market segment by Type, the product can be split into
Reagents
Kits
Instruments
Enzymes
Services
Market segment by Application, split into
Oncology
Non Oncology
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Epigenomic Revenue
1.4 Market by Type
1.4.1 Global Epigenomic Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Reagents
1.4.3 Kits
1.4.4 Instruments
1.4.5 Enzymes
1.4.6 Services
1.5 Market by Application
1.5.1 Global Epigenomic Market Share by Application: 2020 VS 2026
1.5.2 Oncology
1.5.3 Non Oncology
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Epigenomic Market Perspective (2015-2026)
2.2 Global Epigenomic Growth Trends by Regions
2.2.1 Epigenomic Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Epigenomic Historic Market Share by Regions (2015-2020)
2.2.3 Epigenomic Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Epigenomic Market Growth Strategy
2.3.6 Primary Interviews with Key Epigenomic Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Epigenomic Players by Market Size
3.1.1 Global Top Epigenomic Players by Revenue (2015-2020)
3.1.2 Global Epigenomic Revenue Market Share by Players (2015-2020)
3.1.3 Global Epigenomic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Epigenomic Market Concentration Ratio
3.2.1 Global Epigenomic Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Epigenomic Revenue in 2019
3.3 Epigenomic Key Players Head office and Area Served
3.4 Key Players Epigenomic Product Solution and Service
3.5 Date of Enter into Epigenomic Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Epigenomic Historic Market Size by Type (2015-2020)
4.2 Global Epigenomic Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Epigenomic Market Size by Application (2015-2020)
5.2 Global Epigenomic Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Epigenomic Market Size (2015-2020)
6.2 Epigenomic Key Players in North America (2019-2020)
6.3 North America Epigenomic Market Size by Type (2015-2020)
6.4 North America Epigenomic Market Size by Application (2015-2020)
7 Europe
7.1 Europe Epigenomic Market Size (2015-2020)
7.2 Epigenomic Key Players in Europe (2019-2020)
7.3 Europe Epigenomic Market Size by Type (2015-2020)
7.4 Europe Epigenomic Market Size by Application (2015-2020)
8 China
8.1 China Epigenomic Market Size (2015-2020)
8.2 Epigenomic Key Players in China (2019-2020)
8.3 China Epigenomic Market Size by Type (2015-2020)
8.4 China Epigenomic Market Size by Application (2015-2020)
9 Japan
9.1 Japan Epigenomic Market Size (2015-2020)
9.2 Epigenomic Key Players in Japan (2019-2020)
9.3 Japan Epigenomic Market Size by Type (2015-2020)
9.4 Japan Epigenomic Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Epigenomic Market Size (2015-2020)
10.2 Epigenomic Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Epigenomic Market Size by Type (2015-2020)
10.4 Southeast Asia Epigenomic Market Size by Application (2015-2020)
11 India
11.1 India Epigenomic Market Size (2015-2020)
11.2 Epigenomic Key Players in India (2019-2020)
11.3 India Epigenomic Market Size by Type (2015-2020)
11.4 India Epigenomic Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Epigenomic Market Size (2015-2020)
12.2 Epigenomic Key Players in Central & South America (2019-2020)
12.3 Central & South America Epigenomic Market Size by Type (2015-2020)
12.4 Central & South America Epigenomic Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Roche Diagnostics
13.1.1 Roche Diagnostics Company Details
13.1.2 Roche Diagnostics Business Overview
13.1.3 Roche Diagnostics Epigenomic Introduction
13.1.4 Roche Diagnostics Revenue in Epigenomic Business (2015-2020))
13.1.5 Roche Diagnostics Recent Development
13.2 Thermo Fisher Scientific
13.2.1 Thermo Fisher Scientific Company Details
13.2.2 Thermo Fisher Scientific Business Overview
13.2.3 Thermo Fisher Scientific Epigenomic Introduction
13.2.4 Thermo Fisher Scientific Revenue in Epigenomic Business (2015-2020)
13.2.5 Thermo Fisher Scientific Recent Development
13.3 Eisai
13.3.1 Eisai Company Details
13.3.2 Eisai Business Overview
13.3.3 Eisai Epigenomic Introduction
13.3.4 Eisai Revenue in Epigenomic Business (2015-2020)
13.3.5 Eisai Recent Development
13.4 Novartis
13.4.1 Novartis Company Details
13.4.2 Novartis Business Overview
13.4.3 Novartis Epigenomic Introduction
13.4.4 Novartis Revenue in Epigenomic Business (2015-2020)
13.4.5 Novartis Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Epigenomic Key Market Segments
Table 2. Key Players Covered: Ranking by Epigenomic Revenue
Table 3. Ranking of Global Top Epigenomic Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Epigenomic Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Reagents
Table 6. Key Players of Kits
Table 7. Key Players of Instruments
Table 8. Key Players of Enzymes
Table 9. Key Players of Services
Table 10. Global Epigenomic Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Epigenomic Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Epigenomic Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Epigenomic Market Share by Regions (2015-2020)
Table 14. Global Epigenomic Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Epigenomic Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Epigenomic Market Growth Strategy
Table 20. Main Points Interviewed from Key Epigenomic Players
Table 21. Global Epigenomic Revenue by Players (2015-2020) (Million US$)
Table 22. Global Epigenomic Market Share by Players (2015-2020)
Table 23. Global Top Epigenomic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Epigenomic as of 2019)
Table 24. Global Epigenomic by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Epigenomic Product Solution and Service
Table 27. Date of Enter into Epigenomic Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Epigenomic Market Size by Type (2015-2020) (Million US$)
Table 30. Global Epigenomic Market Size Share by Type (2015-2020)
Table 31. Global Epigenomic Revenue Market Share by Type (2021-2026)
Table 32. Global Epigenomic Market Size Share by Application (2015-2020)
Table 33. Global Epigenomic Market Size by Application (2015-2020) (Million US$)
Table 34. Global Epigenomic Market Size Share by Application (2021-2026)
Table 35. North America Key Players Epigenomic Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Epigenomic Market Share (2019-2020)
Table 37. North America Epigenomic Market Size by Type (2015-2020) (Million US$)
Table 38. North America Epigenomic Market Share by Type (2015-2020)
Table 39. North America Epigenomic Market Size by Application (2015-2020) (Million US$)
Table 40. North America Epigenomic Market Share by Application (2015-2020)
Table 41. Europe Key Players Epigenomic Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Epigenomic Market Share (2019-2020)
Table 43. Europe Epigenomic Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Epigenomic Market Share by Type (2015-2020)
Table 45. Europe Epigenomic Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Epigenomic Market Share by Application (2015-2020)
Table 47. China Key Players Epigenomic Revenue (2019-2020) (Million US$)
Table 48. China Key Players Epigenomic Market Share (2019-2020)
Table 49. China Epigenomic Market Size by Type (2015-2020) (Million US$)
Table 50. China Epigenomic Market Share by Type (2015-2020)
Table 51. China Epigenomic Market Size by Application (2015-2020) (Million US$)
Table 52. China Epigenomic Market Share by Application (2015-2020)
Table 53. Japan Key Players Epigenomic Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Epigenomic Market Share (2019-2020)
Table 55. Japan Epigenomic Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Epigenomic Market Share by Type (2015-2020)
Table 57. Japan Epigenomic Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Epigenomic Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Epigenomic Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Epigenomic Market Share (2019-2020)
Table 61. Southeast Asia Epigenomic Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Epigenomic Market Share by Type (2015-2020)
Table 63. Southeast Asia Epigenomic Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Epigenomic Market Share by Application (2015-2020)
Table 65. India Key Players Epigenomic Revenue (2019-2020) (Million US$)
Table 66. India Key Players Epigenomic Market Share (2019-2020)
Table 67. India Epigenomic Market Size by Type (2015-2020) (Million US$)
Table 68. India Epigenomic Market Share by Type (2015-2020)
Table 69. India Epigenomic Market Size by Application (2015-2020) (Million US$)
Table 70. India Epigenomic Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Epigenomic Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Epigenomic Market Share (2019-2020)
Table 73. Central & South America Epigenomic Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Epigenomic Market Share by Type (2015-2020)
Table 75. Central & South America Epigenomic Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Epigenomic Market Share by Application (2015-2020)
Table 77. Roche Diagnostics Company Details
Table 78. Roche Diagnostics Business Overview
Table 79. Roche Diagnostics Product
Table 80. Roche Diagnostics Revenue in Epigenomic Business (2015-2020) (Million US$)
Table 81. Roche Diagnostics Recent Development
Table 82. Thermo Fisher Scientific Company Details
Table 83. Thermo Fisher Scientific Business Overview
Table 84. Thermo Fisher Scientific Product
Table 85. Thermo Fisher Scientific Revenue in Epigenomic Business (2015-2020) (Million US$)
Table 86. Thermo Fisher Scientific Recent Development
Table 87. Eisai Company Details
Table 88. Eisai Business Overview
Table 89. Eisai Product
Table 90. Eisai Revenue in Epigenomic Business (2015-2020) (Million US$)
Table 91. Eisai Recent Development
Table 92. Novartis Company Details
Table 93. Novartis Business Overview
Table 94. Novartis Product
Table 95. Novartis Revenue in Epigenomic Business (2015-2020) (Million US$)
Table 96. Novartis Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Epigenomic Market Share by Type: 2020 VS 2026
Figure 2. Reagents Features
Figure 3. Kits Features
Figure 4. Instruments Features
Figure 5. Enzymes Features
Figure 6. Services Features
Figure 7. Global Epigenomic Market Share by Application: 2020 VS 2026
Figure 8. Oncology Case Studies
Figure 9. Non Oncology Case Studies
Figure 10. Epigenomic Report Years Considered
Figure 11. Global Epigenomic Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Epigenomic Market Share by Regions: 2020 VS 2026
Figure 13. Global Epigenomic Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Epigenomic Market Share by Players in 2019
Figure 16. Global Top Epigenomic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Epigenomic as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Epigenomic Revenue in 2019
Figure 18. North America Epigenomic Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Epigenomic Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Epigenomic Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Epigenomic Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Epigenomic Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Epigenomic Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Epigenomic Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
分子生物学酵素・キット・試薬の世界市場（～2026年） There is a rise in the prevalence of genetic disorders since the recent past, which in turn has driven adoption of molecular diagnostics. Key processes of molecular diagnostics such as epigenetics and polymerase chain reaction (PCR) require molecular biology enzymes, kits & reagents. With mounting i…- ゲノミクス・プロテオミクス試薬・研究キット・分析機器の世界市場（～2026年） The market is segmented into two major areas, namely, the genomics and proteomics reagent kits market and the genomics and proteomics analytical tools market. The reagent and research kits segment deals with the products used in sample preparation, purification and isolation, electrophoresis, lab-on…
- 腫瘍学情報システムの世界市場（～2026年） A system that can manage patient treatment schedules, treatment plans, treatment delivery, treatment summaries, and results is inevitable. An oncology information system (OIS) can be used to manage these data. OIS will encompass the information exchange between radiation therapy departments and the …
- 腫瘍学分子診断の世界市場（～2026年） Market Analysis and Insights: Global Oncology Based Molecular Diagnostic Market The global Oncology Based Molecular Diagnostic market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Oncology Based Molecular Diagnostic Scope a…
- 腫瘍栄養学の世界市場（～2026年） Cancers are among the leading causes of morbidity and mortality worldwide, and the number of new cases is expected to rise significantly over the next decades. Nutritional oncology is an increasingly active interdisciplinary field where cancer is investigated as both a systemic and local disease ori…